Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Ziprasidone treatment of refractory generalized anxiety disorder: a placebo-controlled, double-blind study.

Lohoff FW, Etemad B, Mandos LA, Gallop R, Rickels K.

J Clin Psychopharmacol. 2010 Apr;30(2):185-9. doi: 10.1097/JCP.0b013e3181d21951.

PMID:
20520293
2.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
3.

Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review.

Gao K, Muzina D, Gajwani P, Calabrese JR.

J Clin Psychiatry. 2006 Sep;67(9):1327-40. Review.

PMID:
17017818
4.

Ziprasidone HCl capsules for the adjunctive maintenance treatment of bipolar disorder in adults.

Citrome L.

Expert Rev Neurother. 2010 Jul;10(7):1031-7. doi: 10.1586/ern.10.66. Review.

PMID:
20586686
5.

Efficacy and safety of treatments for refractory generalized anxiety disorder: a systematic review.

Samuel M, Zimovetz EA, Gabriel Z, Beard SM.

Int Clin Psychopharmacol. 2011 Mar;26(2):63-8. doi: 10.1097/YIC.0b013e328341bb4a. Review.

PMID:
21088608
6.

Vortioxetine, a multimodal antidepressant for generalized anxiety disorder: a systematic review and meta-analysis.

Pae CU, Wang SM, Han C, Lee SJ, Patkar AA, Masand PS, Serretti A.

J Psychiatr Res. 2015 May;64:88-98. doi: 10.1016/j.jpsychires.2015.02.017. Epub 2015 Mar 11. Review.

PMID:
25851751
7.

AUGMENTATION STRATEGIES FOR TREATMENT-RESISTANT ANXIETY DISORDERS: A SYSTEMATIC REVIEW AND META-ANALYSIS.

Patterson B, Van Ameringen M.

Depress Anxiety. 2016 Aug;33(8):728-36. doi: 10.1002/da.22525. Epub 2016 May 12. Review.

PMID:
27175543

Supplemental Content

Support Center